SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients.
Merlin Jayalal Lawrence PanchaliChoon-Mee KimJun Won SeoDa-Young KimNa-Ra YunDong Min KimPublished in: Viruses (2023)
Our study demonstrated that SARS-CoV-2 RNAemia is a predictive risk factor for clinical severity in COVID-19 patients. Hence, we showed that blood RNAemia might be a critical marker for disease severity and mortality.